Navigating Cancer Appoints Dr. Ethan Basch as New Scientific Medical Advisor

USA - English

• USA - English

SEATTLE, Sept. 12, 2019 /PRNewswire-PRWeb/ -- Navigating Cancer, the leading provider of oncology patient relationship management software, is pleased to announce that Ethan Basch, MD, MSc, FASCO, has joined as the company's new Scientific Medical Advisor. Dr. Basch is a medical oncologist and distinguished professor in the School of Medicine Division of Hematology/Oncology at University of North Carolina in Chapel Hill (UNC) and a professor in the UNC Gillings School of Global Public Health.

Dr. Basch is a world-renowned patient-reported outcomes researcher and his work has been instrumental in bringing the patient's voice to the forefront of cancer care through patient-reported outcomes (PROs). As a Scientific Medical Advisor, Dr. Basch will work with Navigating Cancer on strategy and implementation of their PRO and remote monitoring solutions in the market, as well as consult on real-world evidence-based national studies on Navigating Cancer's remote monitoring and PRO solutions.

In 2017 Dr. Basch presented a groundbreaking study at ASCO which found that cancer patients who used a web-based survey to report symptoms to their care team during treatment experienced increased overall survival, as well as improved quality of life, longer time on therapy, and fewer ER visits and hospitalizations. Navigating Cancer will leverage Dr. Basch's work and implement studies with his support to prove the same positive impact of PROs on cancer care can be reproduced in a real-world, community oncology setting in rural and diverse patient populations.

"Dr. Basch's research on the use of patient-reported outcomes has been revolutionary in cancer care and we believe that the effective use of PROs in the real world is pivotal to success in value-based care," said Gena Cook, founder and president of Navigating Cancer. "We are looking forward to leveraging Dr. Basch's expertise and research in making patient-reported outcomes a routine part of cancer care throughout our network."

Dr. Basch said, "Navigating Cancer's comprehensive patient platform is associated with reduced ED visits and improved symptom management, and their ability to scale PROs into clinical workflow will continue to enhance this value. Common challenges when incorporating PROs into clinical care are uptake and sustained use by providers. Navigating Cancer directly addresses these challenges with their triage system. I'm excited to help them extend their PRO solution and to ensure that it is leveraging scientific research."

Navigating Cancer's Health Tracker remote monitoring solution allows cancer patients to self-report side effects and oral medication adherence between clinic visits, ensuring their care team can monitor and manage side effects promptly to keep patients on track with their treatment. Dr. Basch will work with Navigating Cancer's team to provide strategic insights on product development and testing.

About Navigating Cancer
Navigating Cancer is the leading Patient Relationship Management technology and solutions company focused on improving the patient experience, delivering more effective care management and enabling oncology care innovation. With over 1,700 providers adopting the Navigating Care platform, it is the most broadly deployed patient management solution in oncology. The company's products combine clinical workflows, oncology content, and data insights to empower personalized patient care for cancer patients inside and outside of the clinic. For more information, please visit http://www.navigatingcancer.com or follow Navigating Cancer on Twitter @navcancer.

SOURCE Navigating Cancer